Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-23

Clinical Trial Update: Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GP2015 to Enbrel in rheumatoid arthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)
  • GP2015 (etanercept biosimilar)

Snippet

Sponsor: Sandoz | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-02-23